Review



human renal cell carcinoma cell line achn  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    ATCC human renal cell carcinoma cell line achn
    Human Renal Cell Carcinoma Cell Line Achn, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1597 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human renal cell carcinoma cell line achn/product/ATCC
    Average 97 stars, based on 1597 article reviews
    human renal cell carcinoma cell line achn - by Bioz Stars, 2026-03
    97/100 stars

    Images



    Similar Products

    human renal cell carcinoma cell line achn  (ATCC)
    97
    ATCC human renal cell carcinoma cell line achn
    Human Renal Cell Carcinoma Cell Line Achn, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human renal cell carcinoma cell line achn/product/ATCC
    Average 97 stars, based on 1 article reviews
    human renal cell carcinoma cell line achn - by Bioz Stars, 2026-03
    97/100 stars
    		  Buy from Supplier
    flow cytometry  (KCAS Bioanalytical and Biomarker Services)
    99
    KCAS Bioanalytical and Biomarker Services flow cytometry
    Flow Cytometry, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flow cytometry/product/KCAS Bioanalytical and Biomarker Services
    Average 99 stars, based on 1 article reviews
    flow cytometry - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    stand hepatic and renal panels  (Quest Diagnostics)
    90
    Quest Diagnostics stand hepatic and renal panels
    Stand Hepatic And Renal Panels, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stand hepatic and renal panels/product/Quest Diagnostics
    Average 90 stars, based on 1 article reviews
    stand hepatic and renal panels - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    human renal cell carcinoma cell line 786 o  (ATCC)
    99
    ATCC human renal cell carcinoma cell line 786 o
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Human Renal Cell Carcinoma Cell Line 786 O, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human renal cell carcinoma cell line 786 o/product/ATCC
    Average 99 stars, based on 1 article reviews
    human renal cell carcinoma cell line 786 o - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    immunogenicity testing  (KCAS Bioanalytical and Biomarker Services)
    99
    KCAS Bioanalytical and Biomarker Services immunogenicity testing
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Immunogenicity Testing, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunogenicity testing/product/KCAS Bioanalytical and Biomarker Services
    Average 99 stars, based on 1 article reviews
    immunogenicity testing - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    sample kitting  (KCAS Bioanalytical and Biomarker Services)
    99
    KCAS Bioanalytical and Biomarker Services sample kitting
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Sample Kitting, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sample kitting/product/KCAS Bioanalytical and Biomarker Services
    Average 99 stars, based on 1 article reviews
    sample kitting - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    dose formulation analysis  (KCAS Bioanalytical and Biomarker Services)
    99
    KCAS Bioanalytical and Biomarker Services dose formulation analysis
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Dose Formulation Analysis, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dose formulation analysis/product/KCAS Bioanalytical and Biomarker Services
    Average 99 stars, based on 1 article reviews
    dose formulation analysis - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    large molecule bioanalysis  (KCAS Bioanalytical and Biomarker Services)
    93
    KCAS Bioanalytical and Biomarker Services large molecule bioanalysis
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Large Molecule Bioanalysis, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/large molecule bioanalysis/product/KCAS Bioanalytical and Biomarker Services
    Average 93 stars, based on 1 article reviews
    large molecule bioanalysis - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    molecular services  (KCAS Bioanalytical and Biomarker Services)
    99
    KCAS Bioanalytical and Biomarker Services molecular services
    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with <t>786-O-FG</t> cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).
    Molecular Services, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/molecular services/product/KCAS Bioanalytical and Biomarker Services
    Average 99 stars, based on 1 article reviews
    molecular services - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with 786-O-FG cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).

    Journal: STAR Protocols

    Article Title: Protocol to generate human stem cell-derived CD70-directed allogeneic CAR-NKT cells for treating renal cell carcinoma

    doi: 10.1016/j.xpro.2025.104340

    Figure Lengend Snippet: Evaluation of the in vitro antitumor efficacy of Allo CAR70-NKT cells (A) Experimental design to study the in vitro antitumor efficacy of Allo CAR70-NKT cells against human RCC cell lines. (B) Schematics showing the indicated human tumor cell lines. (C) Tumor cell killing data at 24 h (n = 4). (D) ELISA analyses of IFN-γ and TNF-α production by Allo CAR70-NKT cells after 24-hour coculture with 786-O-FG cells (n = 4). (E) Experimental design to Study the tumor cell killing mechanisms of Allo CAR70-NKT cells mediated by NKRs. (F) Tumor cell killing data at 24 h (E:T ratio = 0.5:1; n = 4). Representative of 3 experiments. Data are presented as the mean ± SEM. ns, not significant; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 by Student’s t test (D) or one-way ANOVA (C and F).

    Article Snippet: Human renal cell carcinoma cell line 786-O , ATCC , CRL-1932.

    Techniques: In Vitro, Enzyme-linked Immunosorbent Assay